burning mouth syndrome
Information
- Disease name
- burning mouth syndrome
- Disease ID
- DOID:4331
- Description
- "A mouth disease that is characterized by long-lasting burning sensations of the mouth." [url:https\://pubmed.ncbi.nlm.nih.gov/30189984/]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT00001524 | Completed | Phase 2 | Thalidomide to Treat Oral Lesions in HIV-Infected Patients | June 1996 | December 2004 |
NCT00001601 | Completed | N/A | Evaluation and Treatment of Oral Soft Tissue Diseases | August 1997 | August 2002 |
NCT00374673 | Completed | Phase 3 | Efficacy of Transcranial Magnetic Stimulation (TMS) in Chronic Idiopathic Pain Disorders | October 2006 | April 2012 |
NCT02964728 | Completed | Phase 2 | Botulinum Toxin in Burning Mouth Syndrome | November 2015 | May 2016 |
NCT04034849 | Completed | N/A | Effects of Photobiomodulation in Burning Mouth Syndrome | April 1, 2018 | June 30, 2019 |
NCT04203134 | Completed | N/A | Burning Mouth Syndrome Mouth Guard Prospective Study | January 15, 2020 | June 18, 2021 |
NCT04475614 | Completed | N/A | Therapeutic Options for Treatment of Burning Mouth Syndrome | September 15, 2018 | March 31, 2019 |
NCT04535973 | Completed | Hormonal Status and Quality of Life in Female Postmenopausal Patients With Burning Mouth Syndrome | November 15, 2019 | June 15, 2020 | |
NCT04884503 | Completed | Phase 2 | Evaluation of the Effectiveness of the Selected Method of Treatment of Primary Burning Mouth Syndrome | January 12, 2019 | September 6, 2020 |
NCT05309681 | Completed | Salivary Melatonin Levels and Sleep Quality in Patients With Burning Mouth Syndrome | January 7, 2021 | December 15, 2021 | |
NCT05399238 | Completed | Thermography and Burning Mouth Syndrome | May 1, 2022 | May 17, 2022 | |
NCT05816200 | Completed | N/A | Comparison Between Two Treatments for Burning Mouth | April 1, 2021 | June 30, 2022 |
NCT05871580 | Completed | N/A | Effect to the Photobiomodulation in the Burning Mouth Syndrome | May 12, 2023 | January 15, 2024 |
NCT05872789 | Completed | N/A | Impact of Diazepam 1% Oral Gel Efficacy in Burning Mouth Syndrome | May 2, 2020 | October 20, 2023 |
NCT06195137 | Completed | N/A | Caffeine vs. ALA in BMS Treatment. (BMS: Burning Mouth Syndrome. ALA: Alpha-Lipoic Acid.) | December 13, 2021 | June 23, 2023 |
NCT06217731 | Completed | N/A | Inflammatory Markers in Saliva of Patients With Burning Mouth Syndrome | January 10, 2022 | December 10, 2023 |
NCT00862576 | Completed | A Study of the Association of Sleep Dysfunction and Burning Mouth Syndrome | June 2006 | June 2008 | |
NCT00875537 | Completed | N/A | Neurogenic Mechanisms in Burning Mouth Syndrome | January 2009 | June 2010 |
NCT01754740 | Completed | N/A | The Role of Xerostomia in Burning Mouth Syndrome: Case - Control Study | January 2010 | April 2012 |
NCT02382029 | Completed | Early Phase 1 | Acupuncture Versus Clonazepam in Burning Mouth Syndrome | March 2014 | November 2014 |
NCT02580734 | Completed | N/A | Efficacy of Melatonin in Burning Mouth Syndrome (BMS) | March 2014 | October 2015 |
NCT02686359 | Completed | N/A | Opiorphin Levels in Fluids of Burning Mouth Syndrome Patients (OPIODYN) | July 2011 | December 2012 |
NCT02757612 | Completed | N/A | Study Evaluating the Laser Diode Effect Burning Mouth Syndrome | June 2015 | July 30, 2016 |
NCT05059418 | Not yet recruiting | N/A | Burning Mouth Syndrome - New Diagnostic Criteria and Treatment | November 1, 2021 | June 30, 2024 |
NCT06025474 | Recruiting | Phase 3 | Comparison of Vortioxetine Versus Other Antidepressants With Pregabalin Augmentation in Burning Mouth Syndrome | January 1, 2023 | July 24, 2024 |
NCT05729529 | Recruiting | N/A | Impact of Alpha Lipoic Acid Efficacy in Burning Mouth Syndrome | January 20, 2020 | May 30, 2023 |
NCT06040190 | Recruiting | Phase 4 | Effect of Treatments on Pain and Quality of Life in Individual With Burning Mouth Syndrome | November 1, 2023 | October 1, 2024 |
NCT05819697 | Recruiting | Reducing Patient Memory Recall in the Burning Mouth Patient Population | March 14, 2023 | December 30, 2024 | |
NCT00716807 | Terminated | N/A | Efficacy of Nalbuphine and Naloxone Administered as Nose Sprays in the Treatment of Orofacial Pain | January 2008 | June 2010 |
NCT05309070 | Unknown status | N/A | The Efficacy of N-acetyl-cysteine in the Treatment of Burning Mouth Syndrome | May 1, 2022 | February 28, 2024 |
NCT04189367 | Unknown status | Phase 3 | Treatment of Burning Mouth Syndrome With Integration of Traditional Chinese Medicine and Western Medicine | June 20, 2020 | December 2022 |
NCT04313907 | Unknown status | Phase 4 | Low Level Laser Therapy Plus Topical Clonazepam Treatment to Burning Mouth Symdrome | August 16, 2019 | October 16, 2020 |
NCT01867151 | Unknown status | N/A | Effect of Gluten Free Diet in Patients With Burning Mouth Syndrome | May 2013 | March 2014 |
NCT04481841 | Unknown status | Early Phase 1 | Head Yuanshi Dian Therapy in Burning Mouth Syndrome | July 27, 2020 | May 1, 2022 |
NCT00504387 | Unknown status | Burning Mouth Disorder (BMD) - A Neuropathic Pain Disorder | April 2007 | December 2013 | |
NCT02690844 | Withdrawn | Phase 4 | Effectiveness of Mucolox® and Clonazepam in Treatment of Burning Mouth Syndrome | April 2016 | May 2016 |
- Disase is a (Disease Ontology)
- DOID:403
- Cross Reference ID (Disease Ontology)
- GARD:5974
- Cross Reference ID (Disease Ontology)
- MESH:D002054
- Cross Reference ID (Disease Ontology)
- NCI:C62545
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:111349000
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0006430
- Exact Synonym (Disease Ontology)
- Orodynia
- Exact Synonym (Disease Ontology)
- Stomatopyrosis
- MedGen concept unique identifier (MedGen Concept name)
- C0006430
- MedGen unique identifier (MedGen Concept name)
- 14254
- MeSH unique ID (MeSH (Medical Subject Headings))
- D002054